공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

우로키나아제 시장 조사 보고서 : 유형별(우로키나아제 분말, 우로키나아제 용액), 용도별(진료소, 병원) 예측(-2025년) - COVID-19의 누적적 영향

Urokinase Market Research Report by Type (Urokinase Powder and Urokinase Solution), by Application (Clinic and Hospital) - Global Forecast to 2025 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2021년 04월 상품 코드 1000971
페이지 정보 영문 197 Pages
가격
US $ 3,949 ₩ 4,531,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 5,678,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 6,826,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 9,121,000 PDF (Site License) + Excel
US $ 9,949 ₩ 11,416,000 PDF (Enterprise License) + Excel


우로키나아제 시장 조사 보고서 : 유형별(우로키나아제 분말, 우로키나아제 용액), 용도별(진료소, 병원) 예측(-2025년) - COVID-19의 누적적 영향 Urokinase Market Research Report by Type (Urokinase Powder and Urokinase Solution), by Application (Clinic and Hospital) - Global Forecast to 2025 - Cumulative Impact of COVID-19
발행일 : 2021년 04월 페이지 정보 : 영문 197 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 우로키나아제 시장 규모는 2020년 22억 7,709만 달러에서 2025년말까지 26억 9,700만 달러로 성장할 것으로 예측되고 있습니다.

COVID-19는 거의 모든 업계에 영향을 미친 비할 데 없는 세계의 공중보건비상사태이므로 예측 기간 중 업계의 성장에 장기적인 영향을 미칠 것으로 예측됩니다. 360iResearch LLP의 진행중인 조사는 조사 프레임워크를 증폭하고, 기초가 되는 COVID-19의 문제와 향후 잠재적 경로를 확실히 포함하고 있습니다. 조사는 소비자 행동과 수요의 변화, 구입 패턴, 공급망의 재라우팅, 현재 시장 힘의 역학 및 정부의 중요한 개입을 고려한 COVID-19에 관한 인사이트를 제공하고 있습니다. 업데이트된 조사는 시장에 대한 COVID-19의 영향을 고려하고, 인사이트, 분석, 추정 및 예측을 제공합니다.

우로키나아제 시장에 대해 조사했으며, 시장의 개요와 유형별, 용도별, 지역별 동향, COVID-19의 누적적 영향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상년
  • 통화와 가격
  • 언어
  • 제한사항
  • 이해관계자

제2장 조사 방법

  • 조사 프로세스
    • 정의 : 조사 목적
    • 결정 : 조사 디자인
    • 준비 : 조사 기기
    • 수집 : 데이터 소스
    • 분석 : 데이터 해석
    • 책정 : 데이터 검증
    • 공개 : 조사 리포트
    • 반복 : 리포트 업데이트
  • 조사 시행
    • 개시 : 조사 프로세스
    • 계획 : 조사 계획 작성
    • 시행 : 조사 시행
    • 검증 : 발견과 분석
    • 출판물 : 조사 보고
  • 조사 성과

제3장 개요

  • 서론
  • 시장 전망
  • 용도별 전망
  • 유형별 전망
  • 지역별 전망
  • 경쟁사별 전망

제4장 시장 개요

  • 서론
  • COVID-19의 누적적 영향

제5장 시장 인사이트

  • 시장 역학
    • 촉진요인
    • 억제요인
    • 시장 기회
    • 과제
  • Porter의 산업 분석
    • 신규 진출업체의 위협
    • 대체품의 위협
    • 고객의 교섭력
    • 공급 기업의 교섭력
    • 업계의 경쟁

제6장 세계의 우로키나아제 시장, 유형별

  • 우로키나아제 분말
  • 우로키나아제 용액

제7장 세계의 우로키나아제 시장, 용도별

  • 진료소
  • 병원

제8장 아메리카의 우로키나아제 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제9장 아시아태평양의 우로키나아제 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 한국
  • 태국

제10장 유럽, 중동·아프리카의 우로키나아제 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트
  • 영국

제11장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석
  • 경쟁사 SWOT 분석
  • 경쟁 시나리오
    • 합병과 인수
    • 합의, 협업 및 파트너십
    • 신제품 발매와 강화
    • 투자와 자금조달
    • 상, 표창, 확대

제12장 기업의 유저빌리티 개요

  • 4SC AG
  • Eumedica Pharmaceuticals
  • ImaRX Therapeutics
  • Jiangsu Aidea Pharmaceutica
  • Jiangxi Haoran Bio-Pharma
  • Livzon Pharmaceutical Factory of Livzon Group
  • Microbix Biosystems Inc.
  • Nanjing Nanda Pharmaceutical Co. Ltd.
  • NDPharm
  • Salvavidas Pharmaceutical Pvt. Ltd.
  • Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd.
  • Syner-Med Pharmaceuticals
  • Taj Pharmaceuticals Ltd
  • Tianjin Biochemical Pharmaceutical Co. Ltd.
  • Wanhua Biochem
  • Wilex AG
  • Wuhan Humanwell Pharmaceutical Co. Ltd.
  • ZYDUS CADILA HEALTHCARE LTD.

제13장 부록

  • 디스커션 가이드
  • 라이선스와 가격
KSA 21.04.28

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROKINASE MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL UROKINASE MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL UROKINASE MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL UROKINASE MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 8. GLOBAL UROKINASE MARKET: MARKET DYNAMICS
  • FIGURE 9. GLOBAL UROKINASE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 10. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 VS 2025 (%)
  • FIGURE 11. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2025
  • FIGURE 13. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, 2020 VS 2025 (USD MILLION)
  • FIGURE 14. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, 2020 VS 2025 (USD MILLION)
  • FIGURE 15. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (%)
  • FIGURE 16. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2020 VS 2025 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2025
  • FIGURE 18. GLOBAL UROKINASE MARKET SIZE, BY CLINIC, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, 2020 VS 2025 (USD MILLION)
  • FIGURE 20. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 21. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 23. ARGENTINA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 24. BRAZIL UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 25. CANADA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 26. MEXICO UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 27. UNITED STATES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 28. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 29. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 31. AUSTRALIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 32. CHINA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 33. INDIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 34. INDONESIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 35. JAPAN UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 36. MALAYSIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 37. PHILIPPINES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 38. SOUTH KOREA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 39. THAILAND UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 40. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 41. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 43. FRANCE UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. GERMANY UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. ITALY UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 46. NETHERLANDS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 47. QATAR UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 48. RUSSIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. SAUDI ARABIA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. SOUTH AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. SPAIN UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. UNITED KINGDOM UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. GLOBAL UROKINASE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 55. GLOBAL UROKINASE MARKET: MARKET SHARE ANALYSIS
  • FIGURE 56. GLOBAL UROKINASE MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 57. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL UROKINASE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL UROKINASE MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE POWDER, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL UROKINASE MARKET SIZE, BY UROKINASE SOLUTION, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL UROKINASE MARKET SIZE, BY CLINIC, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL UROKINASE MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. AMERICAS UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. AMERICAS UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. ARGENTINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. ARGENTINA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. BRAZIL UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. BRAZIL UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. CANADA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CANADA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. MEXICO UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. MEXICO UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. UNITED STATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. UNITED STATES UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ASIA-PACIFIC UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. ASIA-PACIFIC UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. AUSTRALIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AUSTRALIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CHINA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CHINA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. INDIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. INDIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. INDONESIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. INDONESIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. JAPAN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. JAPAN UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. MALAYSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. MALAYSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. PHILIPPINES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. PHILIPPINES UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. SOUTH KOREA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. SOUTH KOREA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. THAILAND UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. THAILAND UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. FRANCE UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. FRANCE UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. GERMANY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. GERMANY UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. ITALY UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. ITALY UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. NETHERLANDS UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. NETHERLANDS UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. QATAR UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. QATAR UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. RUSSIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. RUSSIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. SAUDI ARABIA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. SAUDI ARABIA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. SOUTH AFRICA UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. SOUTH AFRICA UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. SPAIN UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. SPAIN UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. UNITED ARAB EMIRATES UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. UNITED KINGDOM UROKINASE MARKET SIZE, BY APPLICATION, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. UNITED KINGDOM UROKINASE MARKET SIZE, BY TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. GLOBAL UROKINASE MARKET: SCORES
  • TABLE 69. GLOBAL UROKINASE MARKET: BUSINESS STRATEGY
  • TABLE 70. GLOBAL UROKINASE MARKET: PRODUCT SATISFACTION
  • TABLE 71. GLOBAL UROKINASE MARKET: RANKING
  • TABLE 72. GLOBAL UROKINASE MARKET: MERGER & ACQUISITION
  • TABLE 73. GLOBAL UROKINASE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 74. GLOBAL UROKINASE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 75. GLOBAL UROKINASE MARKET: INVESTMENT & FUNDING
  • TABLE 76. GLOBAL UROKINASE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 77. GLOBAL UROKINASE MARKET: LICENSE & PRICING

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Urokinase Market is expected to grow from USD 2,277.09 Million in 2020 to USD 2,697.00 Million by the end of 2025.

2. The Global Urokinase Market is expected to grow from EUR 1,996.60 Million in 2020 to EUR 2,364.78 Million by the end of 2025.

3. The Global Urokinase Market is expected to grow from GBP 1,774.98 Million in 2020 to GBP 2,102.29 Million by the end of 2025.

4. The Global Urokinase Market is expected to grow from JPY 243,024.10 Million in 2020 to JPY 287,838.37 Million by the end of 2025.

5. The Global Urokinase Market is expected to grow from AUD 3,306.64 Million in 2020 to AUD 3,916.40 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Urokinase to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Urokinase Market studied across Urokinase Powder and Urokinase Solution.

Based on Application, the Urokinase Market studied across Clinic and Hospital.

Based on Geography, the Urokinase Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Urokinase Market including 4SC AG, Eumedica Pharmaceuticals, ImaRX Therapeutics, Jiangsu Aidea Pharmaceutica, Jiangxi Haoran Bio-Pharma, Livzon Pharmaceutical Factory of Livzon Group, Microbix Biosystems Inc., Nanjing Nanda Pharmaceutical Co. Ltd., NDPharm, Salvavidas Pharmaceutical Pvt. Ltd., Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd., Syner-Med Pharmaceuticals, Taj Pharmaceuticals Ltd, Tianjin Biochemical Pharmaceutical Co. Ltd., Wanhua Biochem, Wilex AG, Wuhan Humanwell Pharmaceutical Co. Ltd., and ZYDUS CADILA HEALTHCARE LTD..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Urokinase Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Urokinase Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Urokinase Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Urokinase Market?

4. What is the competitive strategic window for opportunities in the Global Urokinase Market?

5. What are the technology trends and regulatory frameworks in the Global Urokinase Market?

6. What are the modes and strategic moves considered suitable for entering the Global Urokinase Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Type Outlook
  • 3.5. Geography Outlook
  • 3.6. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of pulmonary embolism globally
      • 5.1.1.2. Usage of urokinase in the treatment of cardiovascular disease
      • 5.1.1.3. Growing instances of Intracerebral hemorrhage
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects caused by urokinase such as Urticaria, difficulty in breathing, and swelling of face, lips, tongue, or throat
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research activities for using urokinase in stroke patients
      • 5.1.3.2. Economic development and substantial infrastructure development
    • 5.1.4. Challenges
      • 5.1.4.1. Urokinase is contraindicated in patients suffering from cancer, brain tumor and high blood pressure
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Urokinase Market, By Type

  • 6.1. Introduction
  • 6.2. Urokinase Powder
  • 6.3. Urokinase Solution

7. Global Urokinase Market, By Application

  • 7.1. Introduction
  • 7.2. Clinic
  • 7.3. Hospital

8. Americas Urokinase Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Urokinase Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. South Korea
  • 9.10. Thailand

10. Europe, Middle East & Africa Urokinase Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis
  • 11.4. Competitor SWOT Analysis
  • 11.5. Competitive Scenario
    • 11.5.1. Merger & Acquisition
    • 11.5.2. Agreement, Collaboration, & Partnership
    • 11.5.3. New Product Launch & Enhancement
    • 11.5.4. Investment & Funding
    • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. 4SC AG
  • 12.2. Eumedica Pharmaceuticals
  • 12.3. ImaRX Therapeutics
  • 12.4. Jiangsu Aidea Pharmaceutica
  • 12.5. Jiangxi Haoran Bio-Pharma
  • 12.6. Livzon Pharmaceutical Factory of Livzon Group
  • 12.7. Microbix Biosystems Inc.
  • 12.8. Nanjing Nanda Pharmaceutical Co. Ltd.
  • 12.9. NDPharm
  • 12.10. Salvavidas Pharmaceutical Pvt. Ltd.
  • 12.11. Shandong PKU High-tech Huatai Pharmaceutical Co. Ltd.
  • 12.12. Syner-Med Pharmaceuticals
  • 12.13. Taj Pharmaceuticals Ltd
  • 12.14. Tianjin Biochemical Pharmaceutical Co. Ltd.
  • 12.15. Wanhua Biochem
  • 12.16. Wilex AG
  • 12.17. Wuhan Humanwell Pharmaceutical Co. Ltd.
  • 12.18. ZYDUS CADILA HEALTHCARE LTD.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing
Back to Top
전화 문의
F A Q